Company Filing History:
Years Active: 1995
Title: Mark R Walden: Innovator in Insulin Transformation
Introduction
Mark R Walden is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biotechnology, particularly in the area of insulin production. His innovative work has the potential to impact diabetes treatment and management.
Latest Patents
Mark R Walden holds a patent for a process titled "Process for transforming a human insulin precursor to human insulin." This patent describes a method for converting a human insulin precursor into human insulin. The process involves treating the precursor with trypsin and carboxypeptidase B in an aqueous medium, utilizing specific metal ions to facilitate the transformation. He has 1 patent to his name.
Career Highlights
Walden is associated with Eli Lilly and Company, a leading pharmaceutical firm known for its advancements in diabetes care. His work at Eli Lilly has allowed him to focus on innovative solutions that address critical health challenges.
Collaborations
Some of his notable coworkers include Bruce H Frank and Walker E Prouty. Their collaboration has likely contributed to the success of various projects within the company.
Conclusion
Mark R Walden's contributions to insulin production exemplify the importance of innovation in healthcare. His work continues to pave the way for advancements in diabetes treatment.